{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T17:32:02Z","timestamp":1771608722405,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.numecd.2023.04.012","type":"journal-article","created":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T18:40:47Z","timestamp":1681584047000},"page":"1367-1376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Trends in lipid profiles and control of LDL-C among adults with diabetes in the United States: An analysis of NHANES 2007\u20132018"],"prefix":"10.1016","volume":"33","author":[{"given":"Tian","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengjue","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naifeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2023.04.012_bib1","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/jama.2015.10029","article-title":"Prevalence of and trends in diabetes among adults in the United States, 1988\u20132012","volume":"314","author":"Menke","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2023.04.012_bib2","doi-asserted-by":"crossref","first-page":"517","DOI":"10.7326\/M13-2411","article-title":"Trends in prevalence and control of diabetes in the United States, 1988-1994 and 1999\u20132010","volume":"160","author":"Selvin","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.numecd.2023.04.012_bib3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.amepre.2018.05.018","article-title":"Trends in the prevalence of diabetes among U.S. Adults: 1999-2016","volume":"55","author":"Fang","year":"2018","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.numecd.2023.04.012_bib4","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1001\/jama.2019.19365","article-title":"Prevalence of diabetes by race and ethnicity in the United States, 2011-2016","volume":"322","author":"Cheng","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2023.04.012_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1023\/A:1024467522972","article-title":"A dynamic Markov model for forecasting diabetes prevalence in the United States through 2050","volume":"6","author":"Honeycutt","year":"2003","journal-title":"Health Care Manag Sci"},{"key":"10.1016\/j.numecd.2023.04.012_bib6","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","article-title":"Mortality and cardiovascular disease in type 1 and type 2 diabetes","volume":"376","author":"Rawshani","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2023.04.012_bib7","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.2337\/dc18-0831","article-title":"Trends and disparities in cardiovascular mortality among U.S. Adults with and without self-reported diabetes, 1988-2015","volume":"41","author":"Cheng","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2023.04.012_bib8","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1161\/CIRCULATIONAHA.108.846519","article-title":"Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study","volume":"120","author":"Preis","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2023.04.012_bib9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.diabres.2009.09.017","article-title":"Improvements in risk factor control among persons with diabetes in the United States: evidence and implications for remaining life expectancy","volume":"86","author":"Hoerger","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.numecd.2023.04.012_bib10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1753-0407.2011.00148.x","article-title":"Trends in the control of risk factors for cardiovascular disease among adults with diagnosed diabetes: findings from the National Health and Nutrition Examination Survey 1999-2008","volume":"3","author":"Ford","year":"2011","journal-title":"J Diabetes"},{"key":"10.1016\/j.numecd.2023.04.012_bib11","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1001\/jamainternmed.2019.2396","article-title":"Evaluation of the cascade of diabetes care in the United States, 2005-2016","volume":"179","author":"Kazemian","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.numecd.2023.04.012_bib12","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.2337\/dc21-ad09a","article-title":"Cardiovascular disease and risk management: standards of Medical care in diabetes-2021. Diabetes care 2021;44(suppl. 1):S125-S150","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2023.04.012_bib13","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1001\/archinternmed.2009.296","article-title":"Trends in medication use among US adults with diabetes mellitus: glycemic control at the expense of controlling cardiovascular risk factors","volume":"169","author":"Mann","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.numecd.2023.04.012_bib14","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.2337\/dc20-0097","article-title":"Differences in U.S. Rural-urban trends in diabetes ABCS, 1999-2018","volume":"44","author":"Mercado","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2023.04.012_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2021.9883","article-title":"Trends in prevalence of diabetes and control of risk factors in diabetes among US adults, 1999\u20132018","author":"Wang","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2023.04.012_bib16","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/dom.13625","article-title":"Composite cardiovascular risk factor target achievement and its predictors in US adults with diabetes: the Diabetes Collaborative Registry","volume":"21","author":"Fan","year":"2019","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.numecd.2023.04.012_bib17","unstructured":"NHANES analytic guidance and brief over view for the 2017-March 2020 pre-pandemic data files. National Center for Health Statistics, Center for Disease Control and Prevention.https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/continuousnhanes\/OverviewBrief.aspx?Cycle=2017-2020."},{"key":"10.1016\/j.numecd.2023.04.012_bib18","unstructured":"Centers for Disease Control and Prevention: About the National Health and Nutrition Examination Survey. http:\/\/www.cdc.gov\/nchs\/nhanes\/about_nhanes.htm."},{"key":"10.1016\/j.numecd.2023.04.012_bib19","unstructured":"National Health and Nutrition Examination Survey: questionnaires, datasets, and related documentation. Atlanta: Centers for Disease Control and Prevention. http:\/\/www.cdc.gov\/nchs\/nhanes\/nhanes_questionnaires.htm."},{"key":"10.1016\/j.numecd.2023.04.012_bib21","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/clinchem\/43.11.2183","article-title":"Use of the Friedewald formula to estimate LDL-cholesterol in patients with chronic renal failure on dialysis","volume":"43","author":"Johnson","year":"1997","journal-title":"Clin Chem"},{"key":"10.1016\/j.numecd.2023.04.012_bib22","first-page":"1","article-title":"National center for health Statistics guidelines for analysis of trends","volume":"2","author":"Ingram","year":"2018","journal-title":"Vital Health Stat"},{"key":"10.1016\/j.numecd.2023.04.012_bib23","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.2337\/dc12-2258","article-title":"The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010","volume":"36","author":"Stark Casagrande","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2023.04.012_bib24","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1056\/NEJMsa1213829","article-title":"Achievement of goals in U.S. diabetes care, 1999-2010","volume":"368","author":"Ali","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2023.04.012_bib25","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1001\/jama.2019.3471","article-title":"Resurgence in diabetes-related complications","volume":"321","author":"Gregg","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2023.04.012_bib26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1475-2840-12-26","article-title":"Temporal changes in concentrations of lipids and apolipoprotein B among adults with diagnosed and undiagnosed diabetes, prediabetes, and normoglycemia: findings from the National Health and Nutrition Examination Survey 1988-1991 to 2005-2008","volume":"12","author":"Ford","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.numecd.2023.04.012_bib27","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"Di Angelantonio","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2023.04.012_bib28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCOUTCOMES.110.959247","article-title":"A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk","volume":"4","author":"Sniderman","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.numecd.2023.04.012_bib29","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.2337\/dc11-0209","article-title":"Clinical usefulness of different lipid measures for prediction of coronary heart disease in type 2 diabetes: a report from the Swedish National Diabetes Register","volume":"34","author":"Eliasson","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2023.04.012_bib30","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1161\/01.CIR.102.16.1886","article-title":"VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial","volume":"102","author":"Sacks","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2023.04.012_bib31","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00592-018-1144-9","article-title":"An increased waist-to-hip ratio is a key determinant of atherosclerotic burden in overweight subjects","volume":"55","author":"Scicali","year":"2018","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.numecd.2023.04.012_bib32","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","article-title":"Association between insulin resistance and the development of cardiovascular disease","volume":"17","author":"Ormazabal","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.numecd.2023.04.012_bib33","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nature05487","article-title":"Mechanisms linking obesity with cardiovascular disease","volume":"444","author":"Van Gaal","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.numecd.2023.04.012_bib34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2337\/dc18-1178","article-title":"Adipose tissue insulin resistance in youth on the spectrum from normal weight to obese and from normal glucose tolerance to impaired glucose tolerance to type 2 diabetes","volume":"42","author":"Kim","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2023.04.012_bib35","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/s41366-019-0493-y","article-title":"Participation of white adipose tissue dysfunction on circulating HDL cholesterol and HDL particle size in apparently healthy humans","volume":"44","author":"Ju\u00e1rez-Rojas","year":"2020","journal-title":"Int J Obes"},{"key":"10.1016\/j.numecd.2023.04.012_bib36","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s40618-018-0949-2","article-title":"Adipose insulin resistance is associated with cardiovascular risk factors in polycystic ovary syndrome","volume":"42","author":"Mu","year":"2019","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.numecd.2023.04.012_bib37","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.2337\/dc20-1918","article-title":"Adipose tissue insulin resistance is longitudinally associated with adipose tissue dysfunction, circulating lipids, and dysglycemia: the PROMISE cohort","volume":"44","author":"Semnani-Azad","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2023.04.012_bib38","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1172\/JCI44442","article-title":"Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans","volume":"121","author":"Rhee","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.numecd.2023.04.012_bib39","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2337\/db16-0046","article-title":"Pharmacological targeting of the atherogenic dyslipidemia complex: the next frontier in CVD prevention beyond lowering LDL cholesterol","volume":"65","author":"Xiao","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.numecd.2023.04.012_bib40","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1161\/01.CIR.98.23.2513","article-title":"Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators","volume":"98","author":"Goldberg","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2023.04.012_bib41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(08)60104-X","article-title":"Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis","volume":"371","author":"Kearney","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2023.04.012_bib42","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.numecd.2023.04.012_bib43","first-page":"S68","article-title":"Dyslipidemia management in adults with diabetes","volume":"27","author":"Haffner","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2023.04.012_bib44","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.2337\/dc18-S009","article-title":"9. Cardiovascular disease and risk management: standards of medical care in diabetes-2018","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2023.04.012_bib45","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2023.04.012_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2022.107338","article-title":"Racial, ethnic, and language differences in screening measures for statin therapy following a major guideline change","volume":"164","author":"Kaufmann","year":"2022","journal-title":"Prev Med"},{"key":"10.1016\/j.numecd.2023.04.012_bib47","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2337\/diacare.26.4.991","article-title":"Trends in lipid management among patients with coronary artery disease: has diabetes received the attention it deserves?","volume":"26","author":"Massing","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2023.04.012_bib48","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.2337\/diacare.27.12.2974","article-title":"Sex differences in quality of health care related to ischemic heart disease prevention in patients with diabetes: the translating research into action for Diabetes (TRIAD) study, 2000-2001","volume":"27","author":"Ferrara","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2023.04.012_bib49","doi-asserted-by":"crossref","first-page":"514","DOI":"10.2337\/diacare.28.3.514","article-title":"Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes","volume":"28","author":"Wexler","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2023.04.012_bib50","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2337\/dc07-1244","article-title":"Sex disparities in control and treatment of modifiable cardiovascular disease risk factors among patients with diabetes: translating research into action for diabetes (TRIAD) Study","volume":"31","author":"Ferrara","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2023.04.012_bib51","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s11606-012-2023-7","article-title":"Racial and ethnic differences in cardio-metabolic risk in individuals with undiagnosed diabetes: national Health and Nutrition Examination Survey 1999-2008","volume":"27","author":"Hunt","year":"2012","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.numecd.2023.04.012_bib52","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007207","article-title":"Nativity status and cardiovascular disease Mortality among hispanic adults","volume":"6","author":"Rodriguez","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.numecd.2023.04.012_bib53","doi-asserted-by":"crossref","first-page":"958","DOI":"10.2337\/dc09-1556","article-title":"Diabetes care in black and white veterans in the southeastern U.S","volume":"33","author":"Twombly","year":"2010","journal-title":"Diabetes Care"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093947532300159X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093947532300159X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:25:30Z","timestamp":1760545530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093947532300159X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S093947532300159X"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2023.04.012","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in lipid profiles and control of LDL-C among adults with diabetes in the United States: An analysis of NHANES 2007\u20132018","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2023.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}